Lv3
350 积分 2024-09-19 加入
Degrader–Antibody Conjugates: Emerging New Modality
24天前
已完结
PLGA-based long-acting injectable (LAI) formulations
4个月前
已完结
Bio-enabling strategies to mitigate the pharmaceutical food effect: A mini review
5个月前
已完结
Retrospective analysis of the biopharmaceutics characteristics of solid oral Modified-Release drug products in approved US FDA NDAs designated as Extended-Release or Delayed-Release formulations
5个月前
已完结
Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca
6个月前
已完结
Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
7个月前
已完结
Global landscape of PROTAC: Perspectives from patents, drug pipelines, clinical trials, and licensing transactions
7个月前
已完结
皖公网安备34019202002308
